Godavari Drugs

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE362C01012
  • NSEID:
  • BSEID: 530317
INR
125.00
-0.95 (-0.75%)
BSENSE

Jun 18

BSE+NSE Vol: 1.99 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
{
  "main_header": {
    "sid": 765253,
    "name": "Godavari Drugs",
    "stock_name": "Godavari Drugs",
    "full_name": "Godavari Drugs Ltd",
    "name_url": "stocks-analysis/godavari-drugs",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "125.00",
    "chg": -0.95,
    "chgp": "-0.75%",
    "dir": -1,
    "prev_price": "125.95",
    "mcapval": "128.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 530317,
    "symbol": "",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "India SENSEX",
    "isin": "INE362C01012",
    "curr_date": "Jun 18",
    "curr_time": "",
    "bse_nse_vol": "1.99 k",
    "exc_status": "Active",
    "traded_date": "Jun 18, 2026",
    "traded_date_str": "2026 06 18",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://marketsmojo.motilaloswaluat.com/MOSL-Landingstocks-analysis/godavari-drugs-765253-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Godavari Drugs standalone net profit rises 44.94% in the March 2026 quarter",
        "link": "https://news.google.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?oc=5",
        "imagepath": "",
        "date": "2026-05-28 09:11:50",
        "description": "Godavari Drugs standalone net profit rises 44.94% in the March 2026 quarter  Business Standard..."
      }
    ],
    "total": 1,
    "sid": "765253",
    "stock_news_url": "https://marketsmojo.motilaloswaluat.com/news/godavari-drugs-765253"
  },
  "announcements": [
    {
      "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
      "datetime": "28-May-2026",
      "details": "Please find the enclosed newspaper publication for your information",
      "source": "BSE"
    },
    {
      "caption": "Board Meeting Outcome for Board Meeting Outcome For Outcome Of Board Meeting Held On Wednesday 27Th Day Of May2026",
      "datetime": "27-May-2026",
      "details": "We are enclosing Audited Financial Results for the Quarter ended 31st march 2026 which are approved in Board Meeting which was held today i.e Wednesday 27th Day of May 2026",
      "source": "BSE"
    },
    {
      "caption": "Statement Of Deviation Or Variation In Utilisation Of Funds Raised Through Preferential Issue For The Quarter Ended March 31 2026",
      "datetime": "27-May-2026",
      "details": "Refer Enclosed",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "No <strong>Dividend</strong> history available",
      "data": []
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}
stock-recommendationAnnouncement

Announcement under Regulation 30 (LODR)-Newspaper Publication

28-May-2026 | Source : BSE

Please find the enclosed newspaper publication for your information

Board Meeting Outcome for Board Meeting Outcome For Outcome Of Board Meeting Held On Wednesday 27Th Day Of May2026

27-May-2026 | Source : BSE

We are enclosing Audited Financial Results for the Quarter ended 31st march 2026 which are approved in Board Meeting which was held today i.e Wednesday 27th Day of May 2026

Statement Of Deviation Or Variation In Utilisation Of Funds Raised Through Preferential Issue For The Quarter Ended March 31 2026

27-May-2026 | Source : BSE

Refer Enclosed

stock-recommendationCorporate Actions
Corporate Actions
info
stock-summary
BOARD MEETING

No Upcoming Board Meetings

stock-summary
DIVIDEND

No Dividend history available

stock-summary
SPLITS

No Splits history available

stock-summary
BONUS

No Bonus history available

stock-summary
RIGHTS

No Rights history available